Professor Charles Kolstad of the Stanford Institute for Economic Policy Research (SIEPR) wrote a policy brief that outlines two major reasons the coal industry has been in decline. When you step back and look at the data it is pretty easy to determine that a major increase in coal jobs, especially in the Eastern states is not in the offing. This is in contrast to the mis-information that EPA Administrator Scott Pruitt said last weekend. Beyond the information below Kolstad has a number of other charts and information regarding the coal industry for the past 60 plus years.
Mining operations at Corsa Coal’s Acosta Deep Mine in Friedens, Pennsylvania. Photo by Justin Merriman/Getty Images
Productivity limits growth
Productivity of US coal miners peaked around the year 2000 and except for the past few years has been in a downtrend. Even if the relaxation of regulations helps sustain the recent uptrend I doubt that there will be a huge uptick.
Hot High Tech Stocks To Buy Right Now: Navigant Consulting, Inc.(NCI)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of Navigant Consulting, Inc. (NYSE: NCI) were down 14 percent to $17.02 after the company posted downbeat quarterly results.
Hertz Global Holdings, Inc (NYSE: HTZ) was down, falling around 18 percent to $14.24. Barclays downgraded Hertz from Equal-Weight to Underweight.
Hot High Tech Stocks To Buy Right Now: Cellectis S.A.(CLLS)
Advisors’ Opinion:
- [By Jim Robertson]
Yesterday, small cap clinical-stage biopharmaceutical stock Cellectis SA (NASDAQ: CLLS) reported that they had received notice fromFDA that a clinical hold was placed on both UCART123 ongoing Phase 1 studies -in acute myeloid leukemia (AML) and in blastic plasmacytoid dendritic cell neoplasm (BPDCN). The clinical hold was initiated after Cellectis reported one fatality in the BPDCN clinical trial (ABC study) with the Company now working closelywith the investigators and the FDA in order to resume the trials with an amended protocol including a lowered dosing of UCART123. The FDA has a detailed page about clinical holds which mentions:
- [By Lisa Levin]
Cellectis SA (ADR) (NASDAQ: CLLS) shares dropped 20 percent to $25.70 after announcing FDA clinical hold of UCART123 studies.
Shares of Opiant Pharmaceuticals Inc (NASDAQ: OPNT) were down 10 percent to $35.20. Opiant Pharma named David O'Toole as CFO.
Hot High Tech Stocks To Buy Right Now: NCI, Inc.(NCIT)
Advisors’ Opinion:
- [By Elizabeth Balboa]
Information technology company NCI Inc (NASDAQ: NCIT) reported its $283 million sale to H.I.G. Capital Management for $20 per share in cash.
9. Allied World Assurance
The insurance firms of Allied World Assurance Company Hldgs Ltd (NYSE: AWH) and Fairfax Financial extended the offering period for purchase of outstanding Allied World shares from June 30 to July 5.
